Vulpes Investment Management Pte Ltd, based in Singapore, has acquired voting rights in Oxford BioDynamics PLC. The acquisition took place on August 29, 2023, and Vulpes now holds a total of 14.06% of the voting rights in the company. This represents an increase from their previous position of 12.78% of voting rights. Vulpes Life Sciences Fund and Vulpes Testudo Fund, both based in the Cayman Islands, are the shareholders involved in this acquisition.
The total number of voting rights held by Vulpes Investment Management Pte Ltd in Oxford BioDynamics PLC is 28,448,756. These voting rights are attached to shares with the ISIN code GB00BD5H8572. There are no financial instruments with voting rights associated with this acquisition.
Vulpes Investment Management Pte Ltd is not controlled by any natural person or legal entity and does not control any other undertakings holding an interest in Oxford BioDynamics PLC.
No information is provided regarding proxy voting or additional details related to this acquisition. The completion date of the transaction was August 29, 2023.